Constitutive expression of HIV-VLPs in stably transfected insect cell line for efficient delivery system.

[1]  F. Buonaguro,et al.  Virus-like particle vaccines and adjuvants: the HPV paradigm , 2009, Expert review of vaccines.

[2]  F. Marincola,et al.  Molecular immune signatures of HIV‐1 vaccines in human PBMCs , 2009, FEBS letters.

[3]  F. Buonaguro,et al.  High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts , 2009, Planta.

[4]  F. Buonaguro,et al.  Th2 Polarization in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus (HIV)-Infected Subjects, as Activated by HIV Virus-Like Particles , 2008, Journal of Virology.

[5]  Francesco M. Marincola,et al.  Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation , 2008, BMC Bioinformatics.

[6]  P. Roy,et al.  Virus‑like particles as a vaccine delivery system: Myths and facts , 2008, Human vaccines.

[7]  F. Buonaguro,et al.  DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity. , 2007, Vaccine.

[8]  C. Malboeuf,et al.  Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo. , 2007, Vaccine.

[9]  M. Peeters,et al.  Genetic and phylogenetic characterization of structural genes from non-B HIV-1 subtypes in Italy. , 2006, AIDS research and human retroviruses.

[10]  F. Buonaguro,et al.  Baculovirus-Derived Human Immunodeficiency Virus Type 1 Virus-Like Particles Activate Dendritic Cells and Induce Ex Vivo T-Cell Responses , 2006, Journal of Virology.

[11]  Zhong Huang,et al.  Virus-like particles production in green plants. , 2006, Methods.

[12]  H. Netter,et al.  Hepatitis B Surface Antigen Vector Delivers Protective Cytotoxic T-Lymphocyte Responses to Disease-Relevant Foreign Epitopes , 2006, Journal of Virology.

[13]  F. Marincola,et al.  Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation , 2005, Journal of Translational Medicine.

[14]  F. Buonaguro,et al.  Induction of Systemic and Mucosal Cross-Clade Neutralizing Antibodies in BALB/c Mice Immunized with Human Immunodeficiency Virus Type 1 Clade A Virus-Like Particles Administered by Different Routes of Inoculation , 2005, Journal of Virology.

[15]  K. Schwarz,et al.  Virus-Like Particles as Carriers for T-Cell Epitopes: Limited Inhibition of T-Cell Priming by Carrier-Specific Antibodies , 2005, Journal of Virology.

[16]  E. Park,et al.  Comparative analysis of GFP(UV)-beta1,3-N-acetylglucosaminyltransferase 2 production in two insect-cell-based expression systems. , 2004, Protein expression and purification.

[17]  Tiansen Li,et al.  DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration , 2004, Gene Therapy.

[18]  B. Autran,et al.  Yeast-Derived Human Immunodeficiency Virus Type 1 p55gag Virus-Like Particles Activate Dendritic Cells (DCs) and Induce Perforin Expression in Gag-Specific CD8+ T Cells by Cross-Presentation of DCs , 2003, Journal of Virology.

[19]  C. Leclerc,et al.  In Vivo, Dendritic Cells Can Cross-Present Virus-Like Particles Using an Endosome-to-Cytosol Pathway 1 , 2003, The Journal of Immunology.

[20]  T. Liang,et al.  Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  L. Racioppi,et al.  Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A. , 2002, Antiviral research.

[22]  F. Lechner,et al.  Cross‐presentation of virus‐like particles by skin‐derived CD8– dendritic cells: a dispensable role for TAP , 2002, European journal of immunology.

[23]  M. Estes,et al.  Recombinant Norwalk Virus-Like Particles Administered Intranasally to Mice Induce Systemic and Mucosal (Fecal and Vaginal) Immune Responses , 2001, Journal of Virology.

[24]  J. Fominaya,et al.  Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles. , 2000, Vaccine.

[25]  R. Wagner,et al.  Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques. , 2000, AIDS research and human retroviruses.

[26]  F. Buonaguro,et al.  A novel glycoprotein 120 sequence from an HIV type 1 isolate of the A clade identified in North Uganda. , 1998, AIDS research and human retroviruses.

[27]  S. Sosnovtseva,et al.  Characterization of a recombinant human calicivirus capsid protein expressed in mammalian cells. , 1998, Virus research.

[28]  P. Coursaget,et al.  In vitro gene transfer using human papillomavirus-like particles. , 1998, Nucleic acids research.

[29]  M. Estes,et al.  Rotavirus virus-like particles administered mucosally induce protective immunity , 1997, Journal of virology.

[30]  T. Miyamura,et al.  Expression and self-assembly of empty virus-like particles of hepatitis E virus , 1997, Journal of virology.

[31]  C. Leclerc,et al.  Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  P. Ricciardi-Castagnoli,et al.  Dendritic cells process exogenous viral proteins and virus‐like particles for class I presentation to CD8+ cytotoxic T lymphocytes , 1996, European journal of immunology.

[33]  R. Wagner,et al.  Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles. , 1996, Virology.

[34]  P. Corti,et al.  Heteroduplex mobility assay and phylogenetic analysis of V3 region sequences of human immunodeficiency virus type 1 isolates from Gulu, northern Uganda. The Italian-Ugandan Cooperation AIDS Program , 1995, Journal of virology.

[35]  Y. Fujiwara,et al.  Secretion of biologically active human proapolipoprotein A-I in a baculovirus-insect cell system: protection from degradation by protease inhibitors. , 1995, Journal of lipid research.

[36]  M. Betenbaugh,et al.  Nucleocapsid- and virus-like particles assemble in cells infected with recombinant baculoviruses or vaccinia viruses expressing the M and the S segments of Hantaan virus. , 1995, Virus research.

[37]  G. Devauchelle,et al.  Incorporation of pseudorabies virus gD into human immunodeficiency virus type 1 Gag particles produced in baculovirus-infected cells , 1995, Journal of virology.

[38]  E. Hunter,et al.  Efficient in vivo and in vitro assembly of retroviral capsids from Gag precursor proteins expressed in bacteria , 1995, Journal of virology.

[39]  R. Matthews.  Diagnosis of Plant Virus Diseases , 1993 .

[40]  A. Kingsman,et al.  Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion , 1993, Journal of virology.

[41]  D. Lowy,et al.  Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  S. Zolla-Pazner,et al.  Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine , 1992, Journal of virology.

[43]  S. S. Hong,et al.  Functional domains of HIV-1 gag-polyprotein expressed in baculovirus-infected cells. , 1991, Virology.

[44]  S. Natori,et al.  Production of recombinant sarcotoxin IA in Bombyx mori cells. , 1990, The Biochemical journal.

[45]  D. Jarvis,et al.  Use of Early Baculovirus Promoters for Continuous Expression and Efficient Processing of Foreign Gene Products in Stably Transformed Lepidopteran Cells , 1990, Bio/Technology.

[46]  E. Jacobs,et al.  Assembly and release of HIV-1 precursor Pr55 gag virus-like particles from recombinant baculovirus-infected insect cells , 1989, Cell.

[47]  A. Burny,et al.  The GAG precursor of simian immunodeficiency virus assembles into virus‐like particles. , 1989, The EMBO journal.

[48]  D. Jarvis,et al.  Glycosylation and secretion of human tissue plasminogen activator in recombinant baculovirus-infected insect cells , 1989, Molecular and cellular biology.

[49]  K. Matsubara,et al.  Expression of hepatitis B virus core antigen gene in Saccharomyces cerevisiae: synthesis of two polypeptides translated from different initiation codons , 1986, Journal of virology.

[50]  M. Klowden,et al.  Baculovirus-mediated expression of bacterial genes in dipteran and mammalian cells , 1985, Journal of virology.

[51]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[52]  P. Cruz,et al.  Production of core and virus-like particles with baculovirus infected insect cells. , 2002, Advances in biochemical engineering/biotechnology.

[53]  M. Prevost,et al.  High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A. , 2001, Antiviral research.

[54]  K. Nagashima,et al.  Synthesis and assembly of chimeric human immunodeficiency virus gag pseudovirions. , 1996, Intervirology.